NATIONAL JEWISH HEALTH
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1899-01-01
- Employees
- -
- Market Cap
- -
Progression of Airway Obstruction in Childhood Asthma
Completed
- Conditions
- First Posted Date
- 2009-04-02
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 55
- Registration Number
- NCT00873873
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2009-02-25
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- National Jewish Health
- Registration Number
- NCT00851370
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Markers of Airway Inflammation in BAL Fluid From Children With Asthma
Completed
- Conditions
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 103
- Registration Number
- NCT00838552
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Phase II Study of Digitoxin to Treat Cystic Fibrosis
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 24
- Registration Number
- NCT00782288
- Locations
- ๐บ๐ธ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen
- First Posted Date
- 2008-08-20
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 30
- Registration Number
- NCT00738569
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
Completed
- Conditions
- First Posted Date
- 2008-08-01
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 60
- Registration Number
- NCT00727285
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 30
- Registration Number
- NCT00700921
- Locations
- ๐บ๐ธ
National Jewish Medical and Research Center, Denver, Colorado, United States
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 60
- Registration Number
- NCT00692796
- Locations
- ๐บ๐ธ
National Jewish Medical and Research Center, Denver, Colorado, United States
Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 36
- Registration Number
- NCT00659529
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Evaluating Behavioral Treatments to Improve Adherence to Continuous Positive Airway Pressure (CPAP) Therapy in People With Obstructive Sleep Apnea (The BREATHE Study)
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 306
- Registration Number
- NCT00623246
- Locations
- ๐บ๐ธ
National Jewish Medical and Research Center, Denver, Colorado, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath